Clinical Trials
- Brain, Spinal Cord & Nervous System
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)
- Ages18 years - 65 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Multiple Sclerosis: Symptoms and Hormones Study
- Ages18 years - 45 years
- GenderFemale only
- Brain, Spinal Cord & Nervous System
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid)
- Ages8 years - 65 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
CELLO Study for Radiologically Isolated Syndrome (RIS)
- Ages18 years - 40 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS)
- Ages18 years - 55 years
- GenderBoth
- COVID-19 Outpatient
Magnetic Resonance Imaging Biomarkers: A tool to study central nervous system disease (MBAT)
- Mental Health & Behavioral Research
Eligibility for Participation in Neuroimaging Studies
- Addictive Behavior, Brain, Spinal Cord & Nervous System, Genetics, Mental Health & Behavioral Research
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
- Ages18 years - 55 years
- GenderMale only
- Mental Health & Behavioral Research
Connectivity While Coming of Age
- Ages18 years - 25 years
- GenderBoth
- COVID-19 Inpatient, COVID-19 Outpatient
Patient response to COVID19 outbreak
- Ages18 years and older
- GenderBoth